CSL Ltd (CSL) - Medical Equipment - Deals and Alliances Profile

GlobalData
31 Pages - GLDATA61930
$250.00

Summary

CSL Ltd (CSL) carries out research and development, manufacturing, marketing and distribution of biopharmaceutical and related products. Its product portfolio include plasma-derived products for treating bleeding disorders such as haemophilia and von Willebrand disease, hereditary angioedema, primary and secondary immune deficiencies, inherited respiratory disease and neurological disorders; influenza vaccine; and protein-based medicines for treating serious human illnesses. The company also provides products to prevent haemolytic disease in newborns and infection in solid organ transplant recipients and to treat specific infections and help victims of trauma, shock and burns. CSL also markets an array of vaccines, antivenoms and pharmaceutical products supplied by other manufacturers. The company offers its products in Australia, Germany, Switzerland, the UK, the US and rest of the world. CSL is headquartered in Parkville, Victoria, Australia.

CSL Ltd (CSL) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
CSL Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
CSL Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
CSL Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
CSL Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
CSL Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
CSL Ltd, Medical Equipment, Deal Details 10
Partnerships 10
CSL Behring Enters into Co-Development Agreement with Enable Injections 10
BioCSL Enters into Distribution Agreement with Immucor for Capture 10
Debt Offering 11
CSL Completes Private Placement Of Debt Securities Due 2018 For US$100 Million 11
CSL Completes Private Placement Of Debt Securities Due 2020 For US$150 Million 12
CSL Completes Private Placement Of Debt Securities Due 2023 For US$150 Million 12
CSL Completes Private Placement Of Debt Securities Due 2025 For US$100 Million 13
CSL Completes Private Placement Of Debt Securities For US$750 Million 14
CSL Ltd - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 20
Strategy And Business Planning 20
Mar 07, 2016: Expanded Bio21 to house global research hub 20
Financial Announcements 21
Feb 15, 2017: CSL Announces Half Year Result 2017 21
Jan 19, 2017: CSL reports FY2017 profit upgrade 23
Aug 17, 2016: CSL Announces Full Year Result 2016 24
Feb 16, 2016: CSL: Half Year Result 2016 26
Corporate Communications 29
Aug 17, 2016: CSL Announces Changes to the Board 29
Feb 16, 2016: CSL Appoints New Director 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
CSL Ltd, Medical Equipment, Key Facts, 2016 1
CSL Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
CSL Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
CSL Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
CSL Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
CSL Ltd, Deals By Market, 2011 to YTD 2017 8
CSL Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
CSL Behring Enters into Co-Development Agreement with Enable Injections 10
BioCSL Enters into Distribution Agreement with Immucor for Capture 10
CSL Completes Private Placement Of Debt Securities Due 2018 For US$100 Million 11
CSL Completes Private Placement Of Debt Securities Due 2020 For US$150 Million 12
CSL Completes Private Placement Of Debt Securities Due 2023 For US$150 Million 12
CSL Completes Private Placement Of Debt Securities Due 2025 For US$100 Million 13
CSL Completes Private Placement Of Debt Securities For US$750 Million 14
CSL Ltd, Key Competitors 15
CSL Ltd, Key Employees 16
CSL Ltd, Other Locations 17
CSL Ltd, Subsidiaries 17

List of Figures
CSL Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
CSL Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
CSL Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
CSL Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
CSL Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
CSL Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
CSL Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
CSL Ltd, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838